Sign in / Join Now
ETFs & Funds
"Big Pharma Vies For India's $12 Billion Drug Market." Dr. Reddy's Laboratories (
) is a win-win.
Add a reply...
Latest StockTalks »
people get RDY breaking news and analysis by email alert.
Get email alerts on RDY »
Dr. Reddy's Laboratories Limited
Get latest price
From other sites
Dr. Reddy's Completes Acquisition Of Product Portfolio From TEVA
at TheStreet (Aug 3, 2016)
Credit Suisse Prescribes Underperform Rating For Dr. Reddy's With Drop In U.S. Sales
at Benzinga (Jul 27, 2016)
Dr. Reddy's (RDY) Q1 Earnings and Revenues Decline Y/Y
at Zacks.com (Jul 27, 2016)
Dr. Reddy's Laboratories Breaks Below 200-Day Moving Average - Notable for RDY
at Nasdaq.com (Jul 26, 2016)
Dr. Reddy's Laboratories Ltd (RDY) Ex-Dividend Date Scheduled for July 14, 2016
at Nasdaq.com (Jul 13, 2016)